Plain-English translation of NCT07682662 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
United States
Phase
Post-approval monitoring
Sponsor
University of Mississippi Medical Center
Enrollment target
~400 participants
Started
August 2026
Primary completion
August 2029
Age range
2 Years – 21 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Cynthia Karlson, Ph.D.
University of Mississippi Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.